CSBR vs ICE · P/E 16, rev $56.9M vs P/E 37, rev $12.64B
Champions Oncology Inc (CSBR) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the CSBR and ICE stock pages for the full models.
Not investment advice.